Literature DB >> 23100338

Diagnostic usefulness of ribosomal protein l7/l12 for pneumococcal pneumonia in a mouse model.

Tomoka Sawa1, Soichiro Kimura, Natsue Hosono Honda, Kazue Fujita, Sadako Yoshizawa, Yoshihiro Harada, Yuya Sugiyama, Kenji Matsuyama, Takayuki Sohka, Tsutomu Saji, Keizo Yamaguchi, Kazuhiro Tateda.   

Abstract

The capsular antigen detection (CAD) kit is widely used in clinics to detect Streptococcus pneumoniae infection from urine, because it is rapid, convenient, and effective. However, there are several disadvantages, including false-positive results in children colonized with S. pneumoniae and prolonged positive readings even after the bacteria have been cleared. RP-L7/L12 is a component of the 50S ribosome that is abundant in all bacteria and is specific for each bacterial species. We investigated whether RP-L7/L12 could be used to accurately diagnose pneumococcal pneumonia infection in mouse models of pneumonia and colonization generated by infecting CBA/JN or CBA/N mice, respectively, with S. pneumoniae strain 741. RP-L7/L12 detection by enzyme-linked immunosorbent assay accurately assessed active lung infection, as RP-L7/L12 levels decreased simultaneously with the bacterial lung burden after imipenem administration in the pneumonia mouse model. Based on the data, antibodies detecting RP-L7/L12 were applied to rapid immunochromatographic strips (ICS) for urine sample testing. When we compared the ICS test with the CAD kit in the pneumonia model, the results correlated well. Interestingly, however, when the lung bacterial burden became undetectable after antibiotic treatment, the ICS test was correspondingly negative, even though the same samples tested by the CAD kit remained positive. Similarly, while the ICS test exhibited negative results in the nasal colonization model, the CAD kit demonstrated positive results. Bacterial RP-L7/L12 may be a promising target for the development of new methods to diagnose infectious disease. Further studies are warranted to determine whether such a test could be useful in children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23100338      PMCID: PMC3536183          DOI: 10.1128/JCM.01871-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Immunochromatographic test for rapid detection of Streptococcus pneumoniae in the nasopharynx.

Authors:  David R Murdoch; L Barth Reller
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens.

Authors:  L A Burman; B Trollfors; B Andersson; J Henrichsen; P Juto; I Kallings; T Lagergård; R Möllby; R Norrby
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

Review 3.  Comparative biochemistry and biophysics of ribosomal proteins.

Authors:  A Liljas
Journal:  Int Rev Cytol       Date:  1991

4.  Nonvalue of sputum culture in the management of lower respiratory tract infections.

Authors:  J R Lentino; D A Lucks
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

Review 5.  The L7/L12 ribosomal domain of the ribosome: structural and functional studies.

Authors:  A T Gudkov
Journal:  FEBS Lett       Date:  1997-05-05       Impact factor: 4.124

6.  Monoclonal antibodies against Streptococcus pneumoniae detect epitopes on eubacterial ribosomal proteins L7/L12 and on streptococcal elongation factor Ts.

Authors:  Jan Kolberg; E Arne Høiby; Rodrigo Lopez; Knut Sletten
Journal:  Microbiology (Reading)       Date:  1997-01       Impact factor: 2.777

7.  Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group.

Authors:  B J Marston; J F Plouffe; T M File; B A Hackman; S J Salstrom; H B Lipman; M S Kolczak; R F Breiman
Journal:  Arch Intern Med       Date:  1997 Aug 11-25

8.  Initiation factor and ribosome levels are coordinately controlled in Escherichia coli growing at different rates.

Authors:  J G Howe; J W Hershey
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

9.  Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation.

Authors:  Michael D Smith; Petra Derrington; Rachel Evans; Marjorie Creek; Rhonwen Morris; David A B Dance; Keith Cartwright
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Performance of the Binax NOW Streptococcus pneumoniae urinary antigen assay for diagnosis of pneumonia in children with underlying pulmonary diseases in the absence of acute pneumococcal infection.

Authors:  David Navarro; Leonor García-Maset; Concepción Gimeno; Amparo Escribano; Juan García-de-Lomas
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

View more
  3 in total

1.  Clinical evaluation of a new rapid immunochromatographic test for detection of Bordetella pertussis antigen.

Authors:  Kenji Okada; Yuho Horikoshi; Naoko Nishimura; Shigeki Ishii; Hiroko Nogami; Chikako Motomura; Isao Miyairi; Naoki Tsumura; Toshihiko Mori; Kenta Ito; Shinichi Honma; Kensuke Nagai; Hiroshi Tanaka; Toru Hayakawa; Chiharu Abe; Kazunobu Ouchi
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

2.  Identifying COVID-19-Specific Transcriptomic Biomarkers with Machine Learning Methods.

Authors:  Lei Chen; Zhandong Li; Tao Zeng; Yu-Hang Zhang; KaiYan Feng; Tao Huang; Yu-Dong Cai
Journal:  Biomed Res Int       Date:  2021-07-06       Impact factor: 3.411

3.  Rapid Staphylococcus aureus Detection From Clinical Mastitis Milk by Colloidal Gold Nanoparticle-Based Immunochromatographic Strips.

Authors:  Yuya Nagasawa; Yoshio Kiku; Kazue Sugawara; Naohiro Yabusaki; Kazuyoshi Oono; Kento Fujii; Takahide Suzuki; Koji Maehana; Tomohito Hayashi
Journal:  Front Vet Sci       Date:  2020-01-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.